港股异动 | 派格生物医药-B(02565)最高涨近19% 公司深耕慢病代谢领域延长禁售期彰显长期信心

智通财经05-05

智通财经APP获悉，派格生物医药-B(02565)今日走势强劲，盘中最高涨18.91%，报29.3港元，成交额达5965.98万港元。消息面上，派格生物医药近期公布，基石投资者同意自愿禁售期届满日(即4月30日)起至5月20日不会以任何方式减持任何持股。公司认为，禁售延长表明基石投资者基于公司对推进技术方面的研发能力及在重大临床里程碑方面取得的重大进展，对公司的未来前景充满信心。软库中华此前指，...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2633990288?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2026-05-05 16:03","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2633990288","market":"us","top_or_hot":-1,"title":"港股异动 | 派格生物医药-B(02565)最高涨近19% 公司深耕慢病代谢领域 延长禁售期彰显长期信心","media":"智通财经","content":"<div>\n<p>智通财经APP获悉，派格生物医药-B(02565)今日走势强劲，盘中最高涨18.91%，报29.3港元，成交额达5965.98万港元。消息面上，派格生物医药近期公布，基石投资者同意自愿禁售期届满日(即4月30日)起至5月20日不会以任何方式减持任何持股。公司认为，禁售延长表明基石投资者基于公司对推进技术方面的研发能力及在重大临床里程碑方面取得的重大进展，对公司的未来前景充满信心。软库中华此前指，...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1438070.html\">网页链接</a>\n\n</div>\n","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>港股异动 | 派格生物医药-B(02565)最高涨近19% 公司深耕慢病代谢领域 延长禁售期彰显长期信心</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n港股异动 | 派格生物医药-B(02565)最高涨近19% 公司深耕慢病代谢领域 延长禁售期彰显长期信心\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-05-05 16:03 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/1438070.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP获悉，派格生物医药-B(02565)今日走势强劲，盘中最高涨18.91%，报29.3港元，成交额达5965.98万港元。消息面上，派格生物医药近期公布，基石投资者同意自愿禁售期届满日(即4月30日)起至5月20日不会以任何方式减持任何持股。公司认为，禁售延长表明基石投资者基于公司对推进技术方面的研发能力及在重大临床里程碑方面取得的重大进展，对公司的未来前景充满信心。软库中华此前指，...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1438070.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4588","symbol_name":"碎股","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1438070.html","article_id":"2633990288","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2633990288","pubTimestamp":1777968239,"columns":[],"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"智通财经APP获悉，派格生物医药-B今日走势强劲，盘中最高涨18.91%，报29.3港元，成交额达5965.98万港元。消息面上，派格生物医药近期公布，基石投资者同意自愿禁售期届满日起至5月20日不会以任何方式减持任何持股。公司认为，禁售延长表明基石投资者基于公司对推进技术方面的研发能力及在重大临床里程碑方面取得的重大进展，对公司的未来前景充满信心。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"161726":"生物医药","399441":"生物医药","BK4588":"碎股","XBI":"SPDR S&P Biotech ETF","BK1161":"生物科技","BK4585":"ETF&股票定投概念","BK4581":"高盛持仓","VXUS":"国际股票ETF-Vanguard","02565":"派格生物医药-B"},"translate_title":"Hong Kong stock changes | Paige Biopharmaceutical-B (02565) rose by nearly 19% at the highest. The company is deeply involved in the field of chronic disease metabolism and extends the lock-up period to demonstrate long-term confidence","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"161726":1.5,"399441":1.5,"XBI":1.5,"VXUS":1.5,"02565":1.5},"content_text":"智通财经APP获悉，派格生物医药-B(02565)今日走势强劲，盘中最高涨18.91%，报29.3港元，成交额达5965.98万港元。消息面上，派格生物医药近期公布，基石投资者同意自愿禁售期届满日(即4月30日)起至5月20日不会以任何方式减持任何持股。公司认为，禁售延长表明基石投资者基于公司对推进技术方面的研发能力及在重大临床里程碑方面取得的重大进展，对公司的未来前景充满信心。软库中华此前指，公司是国内少数实现药用聚乙二醇原料自主生产，并将其整合应用于慢性疾病药物全流程开发的企业，通过定向研发具有“新靶标、新作用位点、新作用机制”的创新分子实体，构建了机制互补、兼具临床价值与获益优势的多元化产品管线。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2633990288","isCrawlerRequest":true}

港股异动 | 派格生物医药-B(02565)最高涨近19% 公司深耕慢病代谢领域 延长禁售期彰显长期信心

精彩评论

港股异动 | 派格生物医药-B(02565)最高涨近19% 公司深耕慢病代谢领域延长禁售期彰显长期信心